Abstract
Thought to be an autoimmune inflammatory CNS disease, multiple sclerosis (MS) involves multiple pathologies with heterogeneous clinical presentations. An impaired neurovisceral integration of cardiovascular modulation, indicated by sympathetic and parasympathetic autonomic nervous system (ANS) dysfunction, is among common MS clinical presentations. ANS dysfunction could not only enhance MS inflammatory and neurodegenerative processes, but can also lead to clinical symptoms such as depression, fatigue, sleep disorder, migraine, osteoporosis, and cerebral hemodynamic impairments. Therefore, factors influencing ANS functional activities, in one way or another, will have a significant impact on MS disease course. This review describes the genetic and epigenetic factors, and their interactions with a number of environmental factors contributing to the neurovisceral integration of cardiovascular modulation, with a focus on MS. Future studies should investigate the improvement in cardiovascular ANS function, as a strategy for preventing and minimizing MS-related morbidities, and improving patients’ quality of life.
Similar content being viewed by others
References
Acanfora, D., Pinna, G. D., Gheorghiade, M., Trojano, L., Furgi, G., Maestri, R., et al. (2000). Effect of beta-blockade on the premature ventricular beats/heart rate relation and heart rate variability in patients with coronary heart disease and severe ventricular arrhythmias. American Journal of Therapeutics, 7(4), 229–236.
Anlar, B., Karaszewski, J. W., Reder, A. T., & Arnason, B. G. (1992). Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis. Journal of Neuroimmunology, 36(2–3), 171–177.
Appel, M. L., Berger, R. D., Saul, J. P., Smith, J. M., & Cohen, R. J. (1989). Beat to beat variability in cardiovascular variables: Noise or music? Journal of the American College of Cardiology, 14(5), 1139–1148.
Arata, M., & Sternberg, Z. (2015). Neuroendocrine responses to transvascular autonomic modulation: A modified balloon angioplasty in multiple sclerosis patients. Hormone and Metabolic Research,. doi:10.1055/s-0035-1547235.
Aune, B., Vartun, A., Oian, P., & Sager, G. (2000). Evidence of dysfunctional beta2-adrenoceptor signal system in pre-eclampsia. BJOG: An International Journal of Obstetrics and Gynaecology, 107(1), 116–121.
Barnden, L. R., Crouch, B., Kwiatek, R., Burnet, R., Mernone, A., Chryssidis, S., et al. (2011). A brain MRI study of chronic fatigue syndrome: Evidence of brainstem dysfunction and altered homeostasis. NMR in Biomedicine, 24(10), 1302–1312. doi:10.1002/nbm.1692.
Belfer, I., Buzas, B., Hipp, H., Phillips, G., Taubman, J., Lorincz, I., et al. (2005). Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene. Journal of Human Genetics, 50(1), 12–20. doi:10.1007/s10038-004-0211-y.
Benowitz, N. L., Hukkanen, J., & Jacob, P, I. I. I. (2009). Nicotine chemistry, metabolism, kinetics and biomarkers. Handbook of Experimental Pharmacology, 192, 29–60. doi:10.1007/978-3-540-69248-5_2.
Berger, S., Schulz, S., Kletta, C., Voss, A., & Bar, K. J. (2011). Autonomic modulation in healthy first-degree relatives of patients with major depressive disorder. Progress in Neuropsychopharmacology and Biological Psychiatry, 35(7), 1723–1728. doi:10.1016/j.pnpbp.2011.05.018.
Birnbaum, G., Cree, B., Altafullah, I., Zinser, M., & Reder, A. T. (2008). Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology, 71(18), 1390–1395. doi:10.1212/01.wnl.0000319698.40024.1c.
Bove, R., Musallam, A., Healy, B. C., Raghavan, K., Glanz, B. I., Bakshi, R., et al. (2014). Low testosterone is associated with disability in men with multiple sclerosis. Multiple Sclerosis, 20(12), 1584–1592. doi:10.1177/1352458514527864.
Brenner, T., Timore, Y., Wirguin, I., Abramsky, O., & Steinitz, M. (1989). In vitro synthesis of antibodies to acetylcholine receptor by Epstein–Barr virus-stimulated B-lymphocytes derived from patients with myasthenia gravis. Journal of Neuroimmunology, 24(3), 217–222.
Brezinova, M., Goldenberg, Z., & Kucera, P. (2004). Autonomic nervous system dysfunction in multiple sclerosis patients. Bratislavske Lekarske Listy, 105(12), 404–407.
Brioni, J. D., Decker, M. W., Sullivan, J. P., & Arneric, S. P. (1997). The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Advances in Pharmacology, 37, 153–214.
Brown, T. J., Clark, A. S., & MacLusky, N. J. (1987). Regional sex differences in progestin receptor induction in the rat hypothalamus: Effects of various doses of estradiol benzoate. Journal of Neuroscience, 7(8), 2529–2536.
Carter, J. B., Banister, E. W., & Blaber, A. P. (2003). The effect of age and gender on heart rate variability after endurance training. Medicine and Science in Sports and Exercise, 35(8), 1333–1340. doi:10.1249/01.MSS.0000079046.01763.8F.
Chen, M. J., Nguyen, T. V., Pike, C. J., & Russo-Neustadt, A. A. (2007). Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cellular Signalling, 19(1), 114–128. doi:10.1016/j.cellsig.2006.05.028.
Chen, W. R., Shi, X. M., Yang, T. S., Zhao, L. C., & Gao, L. G. (2013). Protective effect of metoprolol on arrhythmia and heart rate variability in healthy people with 24 hours of sleep deprivation. Journal of Interventional Cardiac Electrophysiology, 36(3), 267–272. doi:10.1007/s10840-012-9728-8.
Choi, J. B., Hong, S., Nelesen, R., Bardwell, W. A., Natarajan, L., Schubert, C., et al. (2006). Age and ethnicity differences in short-term heart-rate variability. Psychosomatic Medicine, 68(3), 421–426. doi:10.1097/01.psy.0000221378.09239.6a.
Cohen, H., Loewenthal, U., Matar, M., & Kotler, M. (2001). Heart rate variability in schizophrenic patients treated with antipsychotic agents. Harefuah, 140(12), 1142–1147.
Cohen, M. A., & Taylor, J. A. (2002). Short-term cardiovascular oscillations in man: Measuring and modelling the physiologies. Journal of Physiology, 542(Pt 3), 669–683.
Comini-Frota, E. R., Rodrigues, D. H., Miranda, E. C., Brum, D. G., Kaimen-Maciel, D. R., Donadi, E. A., et al. (2012). Serum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple sclerosis. Brazilian Journal of Medical and Biological Research, 45(1), 68–71.
Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., & Moreau, T. (1998). Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. New England Journal of Medicine, 339(5), 285–291. doi:10.1056/NEJM199807303390501.
Cook, K. F., Molton, I. R., & Jensen, M. P. (2011). Fatigue and aging with a disability. Archives of Physical Medicine and Rehabilitation, 92(7), 1126–1133. doi:10.1016/j.apmr.2011.02.017.
Cosentino, M., Zaffaroni, M., Marino, F., Bombelli, R., Ferrari, M., Rasini, E., et al. (2002). Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: Effect of cell stimulation and possible relevance for activation-induced apoptosis. Journal of Neuroimmunology, 133(1–2), 233–240.
Cossburn, M., Ingram, G., Hirst, C., Ben-Shlomo, Y., Pickersgill, T. P., & Robertson, N. P. (2012). Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Multiple Sclerosis, 18(1), 45–54. doi:10.1177/1352458511417479.
Crayton, H. J., & Rossman, H. S. (2006). Managing the symptoms of multiple sclerosis: A multimodal approach. Clinical Therapeutics, 28(4), 445–460. doi:10.1016/j.clinthera.2006.04.005.
Cree, B. A., Al-Sabbagh, A., Bennett, R., & Goodin, D. (2005). Response to interferon beta-1a treatment in African American multiple sclerosis patients. Archives of Neurology, 62(11), 1681–1683. doi:10.1001/archneur.62.11.1681.
Czubak, A., Nowakowska, E., Golembiowska, K., Kus, K., Burda, K., & Metelska, J. (2010). Effect of venlafaxine and nicotine on the level of neurotransmitters and their metabolites in rat brains. Journal of Physiology and Pharmacology, 61(3), 339–346.
Daugherty, S. A., Henry, B. E., Peterson, D. L., Swarts, R. L., Bastien, S., & Thomas, R. S. (1991). Chronic fatigue syndrome in northern Nevada. Reviews of Infectious Diseases, 13(Suppl 1), S39–S44.
Del Rio, G., Verlardo, A., Zizzo, G., Marrama, P., & Della Casa, L. (1993). Sex differences in catecholamine response to clonidine. International Journal of Obesity and Related Metabolic Disorders, 17(8), 465–469.
Di Pauli, F., Reindl, M., Ehling, R., Schautzer, F., Gneiss, C., Lutterotti, A., et al. (2008). Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Multiple Sclerosis, 14(8), 1026–1030. doi:10.1177/1352458508093679.
Dinacci, D., Tessitore, A., Russo, A., De Bonis, M. L., Lavorgna, L., Picconi, O., et al. (2011). BDNF Val66Met polymorphism and brain volumes in multiple sclerosis. Neurological Sciences, 32(1), 117–123. doi:10.1007/s10072-010-0433-z.
Djelilovic-Vranic, J., & Alajbegovic, A. (2012). Role of early viral infections in development of multiple sclerosis. Medicinski Arhiv, 66(3 Suppl 1), 37–40.
Dolic, K., Weinstock-Guttman, B., Marr, K., Valnarov, V., Carl, E., Hagemeier, J., et al. (2011). Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers. PLoS One, 6(11), e28062. doi:10.1371/journal.pone.0028062.
Ebstein, R. P., Steinitz, M., Mintzer, J., Lipshitz, I., & Stessman, J. (1985). Beta-adrenergic-stimulated adenylate cyclase activity in normal and EBV-transformed lymphocytes. Experientia, 41(12), 1552–1554.
Eckberg, D. L. (1980). Nonlinearities of the human carotid baroreceptor-cardiac reflex. Circulation Research, 47(2), 208–216.
Eckberg, D. L. (1997). Sympathovagal balance: A critical appraisal. Circulation, 96(9), 3224–3232.
Eckberg, D. L., Mohanty, S. K., & Raczkowska, M. (1984). Trigeminal-baroreceptor reflex interactions modulate human cardiac vagal efferent activity. Journal of Physiology, 347, 75–83.
Esler, M., Eikelis, N., Schlaich, M., Lambert, G., Alvarenga, M., Kaye, D., et al. (2008). Human sympathetic nerve biology: Parallel influences of stress and epigenetics in essential hypertension and panic disorder. Annals of the New York Academy of Sciences, 1148, 338–348. doi:10.1196/annals.1410.064.
Esler, M. D., Thompson, J. M., Kaye, D. M., Turner, A. G., Jennings, G. L., Cox, H. S., et al. (1995). Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation, 91(2), 351–358.
Evans, J. M., Ziegler, M. G., Patwardhan, A. R., Ott, J. B., Kim, C. S., Leonelli, F. M., et al. (2001). Gender differences in autonomic cardiovascular regulation: Spectral, hormonal, and hemodynamic indexes. Journal of Applied Physiology (1985), 91(6), 2611–2618.
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985). The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care, 8(5), 491–498.
Fagius, J., & Sundlof, G. (1986). The diving response in man: Effects on sympathetic activity in muscle and skin nerve fascicles. Journal of Physiology, 377, 429–443.
Flachenecker, P., Reiners, K., Krauser, M., Wolf, A., & Toyka, K. V. (2001). Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Multiple Sclerosis, 7(5), 327–334.
Flachenecker, P., Rufer, A., Bihler, I., Hippel, C., Reiners, K., Toyka, K. V., et al. (2003). Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology, 61(6), 851–853.
Flachenecker, P., Wolf, A., Krauser, M., Hartung, H. P., & Reiners, K. (1999). Cardiovascular autonomic dysfunction in multiple sclerosis: Correlation with orthostatic intolerance. Journal of Neurology, 246(7), 578–586.
Follesa, P., Biggio, F., Gorini, G., Caria, S., Talani, G., Dazzi, L., et al. (2007). Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Research, 1179, 28–34. doi:10.1016/j.brainres.2007.08.045.
Gage, J. R., Fonarow, G., Hamilton, M., Widawski, M., Martinez-Maza, O., & Vredevoe, D. L. (2004). Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure. NeuroImmunoModulation, 11(3), 173–180. doi:10.1159/000076766.
Gardiner, J., Barton, D., Marc, J., & Overall, R. (2007). Potential role of tubulin acetylation and microtubule-based protein trafficking in familial dysautonomia. Traffic, 8(9), 1145–1149. doi:10.1111/j.1600-0854.2007.00605.x.
Gautam, S., Shankar, N., Tandon, O. P., & Goel, N. (2011). Comparison of cardiac autonomic functions among postmenopausal women with and without hormone replacement therapy, and premenopausal women. Indian Journal of Physiology and Pharmacology, 55(4), 297–303.
Ghadirian, P., Dadgostar, B., Azani, R., & Maisonneuve, P. (2001). A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Canadian Journal of Public Health, 92(4), 281–285.
Giorelli, M., Livrea, P., & Trojano, M. (2004). Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients. Journal of Neuroimmunology, 155(1–2), 143–149. doi:10.1016/j.jneuroim.2004.05.013.
Glassman, A. H., Stetner, F., Walsh, B. T., Raizman, P. S., Fleiss, J. L., Cooper, T. B., et al. (1988). Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA, 259(19), 2863–2866.
Goldberger, J. J., Challapalli, S., Tung, R., Parker, M. A., & Kadish, A. H. (2001). Relationship of heart rate variability to parasympathetic effect. Circulation, 103(15), 1977–1983.
Grandner, M. A., Hale, L., Jackson, N., Patel, N. P., Gooneratne, N. S., & Troxel, W. M. (2012). Perceived racial discrimination as an independent predictor of sleep disturbance and daytime fatigue. Behavioral Sleep Medicine, 10(4), 235–249. doi:10.1080/15402002.2012.654548.
Gunal, D. I., Afsar, N., Tanridag, T., & Aktan, S. (2002). Autonomic dysfunction in multiple sclerosis: Correlation with disease-related parameters. European Neurology, 48(1), 1–5.
Haass, M., & Kubler, W. (1997). Nicotine and sympathetic neurotransmission. Cardiovascular Drugs and Therapy, 10(6), 657–665.
Hakamada-Taguchi, R., Uehara, Y., Kuribayashi, K., Numabe, A., Saito, K., Negoro, H., et al. (2003). Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circulation Research, 93(10), 948–956. doi:10.1161/01.RES.0000101298.76864.14.
Hamaad, A., Sosin, M., Lip, G. Y., & MacFadyen, R. J. (2005). Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure. Cardiovascular Drugs and Therapy, 19(3), 183–187. doi:10.1007/s10557-005-2219-8.
Heathers, J. A. (2014). Everything Hertz: Methodological issues in short-term frequency-domain HRV. Frontiers in Physiology, 5, 177. doi:10.3389/fphys.2014.00177.
Hedstrom, A. K., Baarnhielm, M., Olsson, T., & Alfredsson, L. (2009). Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology, 73(9), 696–701. doi:10.1212/WNL.0b013e3181b59c40.
Hedstrom, A. K., Hillert, J., Olsson, T., & Alfredsson, L. (2013). Nicotine might have a protective effect in the etiology of multiple sclerosis. Multiple Sclerosis, 19(8), 1009–1013. doi:10.1177/1352458512471879.
Hedstrom, A. K., Sundqvist, E., Baarnhielm, M., Nordin, N., Hillert, J., Kockum, I., et al. (2011). Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain, 134(Pt 3), 653–664. doi:10.1093/brain/awq371.
Heishman, S. J., Kleykamp, B. A., & Singleton, E. G. (2010). Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl), 210(4), 453–469. doi:10.1007/s00213-010-1848-1.
Hernan, M. A., Jick, S. S., Logroscino, G., Olek, M. J., Ascherio, A., & Jick, H. (2005). Cigarette smoking and the progression of multiple sclerosis. Brain, 128(Pt 6), 1461–1465. doi:10.1093/brain/awh471.
Hernan, M. A., Olek, M. J., & Ascherio, A. (2001). Cigarette smoking and incidence of multiple sclerosis. American Journal of Epidemiology, 154(1), 69–74.
Hinojosa-Laborde, C., Chapa, I., Lange, D., & Haywood, J. R. (1999). Gender differences in sympathetic nervous system regulation. Clinical and Experimental Pharmacology and Physiology, 26(2), 122–126.
Huikuri, H. V., Pikkujamsa, S. M., Airaksinen, K. E., Ikaheimo, M. J., Rantala, A. O., Kauma, H., et al. (1996). Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation, 94(2), 122–125.
Itoh, Y., Oishi, T., Ohnishi, A., Murai, Y., & Imawatari, R. (1993). Acute cerebellar ataxia with sympathotonic orthostatic hypotension following Epstein–Barr virus infection—A case report. Rinsho Shinkeigaku, 33(5), 503–506.
Jason, L. A., Corradi, K., Torres-Harding, S., Taylor, R. R., & King, C. (2005). Chronic fatigue syndrome: The need for subtypes. Neuropsychology Review, 15(1), 29–58.
Jernas, L., Piorunek, T., Tokarz, E., Wygladalska-Jernas, H., Kozubski, W., & Michalak, S. (2012). The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients. Przeglad Lekarski, 69(10), 750–752.
Johnson, J. A., & Liggett, S. B. (2011). Cardiovascular pharmacogenomics of adrenergic receptor signaling: Clinical implications and future directions. Clinical Pharmacology and Therapeutics, 89(3), 366–378. doi:10.1038/clpt.2010.315.
Johnson, J. A., Zineh, I., Puckett, B. J., McGorray, S. P., Yarandi, H. N., & Pauly, D. F. (2003). Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clinical Pharmacology and Therapeutics, 74(1), 44–52. doi:10.1016/S0009-9236(03)00068-7.
Kamath, M. V., & Fallen, E. L. (1993). Power spectral analysis of heart rate variability: A noninvasive signature of cardiac autonomic function. Critical Reviews in Biomed Eng, 21(3), 245–311.
Karakaya, O., Barutcu, I., Kaya, D., Esen, A. M., Saglam, M., Melek, M., et al. (2007). Acute effect of cigarette smoking on heart rate variability. Angiology, 58(5), 620–624. doi:10.1177/0003319706294555.
Kataoka, Y., Niwa, M., Yamashita, K., & Taniyama, K. (1994). GABA receptor function in the parasympathetic ganglia. Japanese Journal of Physiology, 44(Suppl 2), S125–S129.
Kawashima, K., Fujii, T., Moriwaki, Y., & Misawa, H. (2012). Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. Life Sciences, 91(21–22), 1027–1032. doi:10.1016/j.lfs.2012.05.006.
Kennett, A., Heal, D. J., & Wonnacott, S. (2012). Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypes. Nicotine and Tobacco Research, 14(11), 1339–1345. doi:10.1093/ntr/nts128.
Kingwell, B. A., Thompson, J. M., Kaye, D. M., McPherson, G. A., Jennings, G. L., & Esler, M. D. (1994). Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation, 90(1), 234–240.
Klimek, V., Zhu, M. Y., Dilley, G., Konick, L., Overholser, J. C., Meltzer, H. Y., et al. (2001). Effects of long-term cigarette smoking on the human locus coeruleus. Archives of General Psychiatry, 58(9), 821–827.
Klineova, S., Nicholas, J., & Walker, A. (2012). Response to disease modifying therapies in African Americans with multiple sclerosis. Ethnicity and Disease, 22(2), 221–225.
Koch, M. W., Metz, L. M., & Kovalchuk, O. (2013). Epigenetic changes in patients with multiple sclerosis. Nature Reviews Neurology, 9(1), 35–43. doi:10.1038/nrneurol.2012.226.
Koch, M., van Harten, A., Uyttenboogaart, M., & De Keyser, J. (2007). Cigarette smoking and progression in multiple sclerosis. Neurology, 69(15), 1515–1520. doi:10.1212/01.wnl.0000277658.78381.db.
Kodounis, A., Stamboulis, E., Constantinidis, T. S., & Liolios, A. (2005). Measurement of autonomic dysregulation in multiple sclerosis. Acta Neurologica Scandinavica, 112(6), 403–408. doi:10.1111/j.1600-0404.2005.00446.x.
Kohm, A. P., & Sanders, V. M. (2001). Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+T and B lymphocyte function in vitro and in vivo. Pharmacological Reviews, 53(4), 487–525.
Kollai, M., & Mizsei, G. (1990). Respiratory sinus arrhythmia is a limited measure of cardiac parasympathetic control in man. Journal of Physiology, 424, 329–342.
Krakauer, M., Sorensen, P. S., Khademi, M., Olsson, T., & Sellebjerg, F. (2006). Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis. Scandinavian Journal of Immunology, 64(2), 155–163. doi:10.1111/j.1365-3083.2006.01788.x.
Kruijver, F. P., Balesar, R., Espila, A. M., Unmehopa, U. A., & Swaab, D. F. (2002). Estrogen receptor-alpha distribution in the human hypothalamus in relation to sex and endocrine status. Journal of Comparative Neurology, 454(2), 115–139. doi:10.1002/cne.10416.
Kuppers, R. (2003). B cells under influence: Transformation of B cells by Epstein–Barr virus. Nature Reviews Immunology, 3(10), 801–812. doi:10.1038/nri1201.
Kvistad, S., Myhr, K. M., Holmoy, T., Bakke, S., Beiske, A. G., Bjerve, K. S., et al. (2014). Antibodies to Epstein–Barr virus and MRI disease activity in multiple sclerosis. Multiple Sclerosis, 20(14), 1833–1840. doi:10.1177/1352458514533843.
Lampert, R., Ickovics, J., Horwitz, R., & Lee, F. (2005). Depressed autonomic nervous system function in African Americans and individuals of lower social class: A potential mechanism of race- and class-related disparities in health outcomes. American Heart Journal, 150(1), 153–160. doi:10.1016/j.ahj.2004.08.008.
Lang, U. E., Hellweg, R., & Gallinat, J. (2004). BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology, 29(4), 795–798. doi:10.1038/sj.npp.1300382.
Lang, U. E., Hellweg, R., Sander, T., & Gallinat, J. (2009). The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Molecular Psychiatry, 14(2), 120–122. doi:10.1038/mp.2008.80.
Lanzillo, R., Mancini, M., Liuzzi, R., Di Donato, O., Salvatore, E., Maglio, V., et al. (2013). Chronic cerebrospinal venous insufficiency in multiple sclerosis: A highly prevalent age-dependent phenomenon. BMC Neurology, 13, 20. doi:10.1186/1471-2377-13-20.
Lappano, R., Rosano, C., De Marco, P., De Francesco, E. M., Pezzi, V., & Maggiolini, M. (2010). Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Molecular and Cellular Endocrinology, 320(1–2), 162–170. doi:10.1016/j.mce.2010.02.006.
Laustiola, K. E., Lassila, R., Kaprio, J., & Koskenvuo, M. (1988). Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking. Circulation, 78(5 Pt 1), 1234–1240.
Lee, J., Hwang, Y. J., Shin, J. Y., Lee, W. C., Wie, J., Kim, K. Y., et al. (2013). Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington’s disease. Acta Neuropathologica, 125(5), 727–739. doi:10.1007/s00401-013-1103-z.
Leicht, A. S., Hirning, D. A., & Allen, G. D. (2003). Heart rate variability and endogenous sex hormones during the menstrual cycle in young women. Experimental Physiology, 88(3), 441–446.
Leone, A. (2011). Does smoking act as a friend or enemy of blood pressure? Let release Pandora’s box. Cardiology Research And Practice, 2011, 264894. doi:10.4061/2011/264894.
Leray, E., Yaouanq, J., Le Page, E., Coustans, M., Laplaud, D., Oger, J., et al. (2010). Evidence for a two-stage disability progression in multiple sclerosis. Brain, 133(Pt 7), 1900–1913. doi:10.1093/brain/awq076.
Levin, E. D., McClernon, F. J., & Rezvani, A. H. (2006). Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl), 184(3–4), 523–539. doi:10.1007/s00213-005-0164-7.
Levin, E. D., & Simon, B. B. (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl), 138(3–4), 217–230.
Liao, D., Barnes, R. W., Chambless, L. E., Simpson, R. J, Jr, Sorlie, P., & Heiss, G. (1995). Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability—The ARIC study. atherosclerosis risk in communities. American Journal of Cardiology, 76(12), 906–912.
Liu, J., Liu, Z. Q., Tan, Z. R., Chen, X. P., Wang, L. S., Zhou, G., et al. (2003). Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clinical Pharmacology and Therapeutics, 74(4), 372–379. doi:10.1016/S0009-9236(03)00224-8.
Liu, X., Zhu, X., Wang, A., Fan, H., & Yuan, H. (2009). Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis. International Journal of Cardiology, 137(3), 282–288. doi:10.1016/j.ijcard.2009.09.540.
Lopez-Navidad, A., Domingo, P., Lopez-Talavera, J. C., Rabella, N., & Verger, G. (1996). Epstein–Barr virus infection associated with interstitial nephritis and chronic fatigue. Scandinavian Journal of Infectious Diseases, 28(2), 185–187.
Lucas, R. M., Ponsonby, A. L., Dear, K., Valery, P., Pender, M. P., Burrows, J. M., et al. (2011). Current and past Epstein–Barr virus infection in risk of initial CNS demyelination. Neurology, 77(4), 371–379. doi:10.1212/WNL.0b013e318227062a.
Lucini, D., Bertocchi, F., Malliani, A., & Pagani, M. (1996). A controlled study of the autonomic changes produced by habitual cigarette smoking in healthy subjects. Cardiovascular Research, 31(4), 633–639.
Malik, M., & Camm, A. J. (1993). Components of heart rate variability—What they really mean and what we really measure. American Journal of Cardiology, 72(11), 821–822.
Malliani, A., Pagani, M., Lombardi, F., & Cerutti, S. (1991). Cardiovascular neural regulation explored in the frequency domain. Circulation, 84(2), 482–492.
Mann, M. C., Exner, D. V., Hemmelgarn, B. R., Turin, T. C., Sola, D. Y., & Ahmed, S. B. (2012). Impact of gender on the cardiac autonomic response to angiotensin II in healthy humans. Journal of Applied Physiology (1985), 112(6), 1001–1007. doi:10.1152/japplphysiol.01207.2011.
Marchione, P., Morreale, M., Giacomini, P., Izzo, C., Pontecorvo, S., Altieri, M., et al. (2014). Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: A case-control study. PLoS One, 9(10), e111486. doi:10.1371/journal.pone.0111486.
Marien, M. R., Colpaert, F. C., & Rosenquist, A. C. (2004). Noradrenergic mechanisms in neurodegenerative diseases: A theory. Brain Research. Brain Research Reviews, 45(1), 38–78. doi:10.1016/j.brainresrev.2004.02.002.
Mazzeo, R. S., Rajkumar, C., Jennings, G., & Esler, M. (1997). Norepinephrine spillover at rest and during submaximal exercise in young and old subjects. Journal of Applied Physiology (1985), 82(6), 1869–1874.
McGregor, R., & Siegel, J. M. (2010). Illuminating the locus coeruleus: Control of posture and arousal. Nature Neuroscience, 13(12), 1448–1449. doi:10.1038/nn1210-1448.
Melamed, M., Castano, E., Notides, A. C., & Sasson, S. (1997). Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol. Molecular Endocrinology, 11(12), 1868–1878. doi:10.1210/mend.11.12.0025.
Meyer, P., Kurtz, K., Thomae, E., Becker, G., Schildan, A., Patt, M., et al. (2010). Reduced cortical {alpha}4β2* nicotinic acetylcholine receptor binding and its relationship to impaired memory and attention in early stage multiple sclerosis: A 2-[18F]F-A-85380 (2FA) PET study. Abstract-Journal Nuclear Medcine, 51(Suppl 2), 1792.
Meyer, E. L., Yoshikami, D., & McIntosh, J. M. (2008). The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices. Journal of Neurochemistry, 105(5), 1761–1769. doi:10.1111/j.1471-4159.2008.05266.x.
Minden, S. L., & Schiffer, R. B. (1990). Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Archives of Neurology, 47(1), 98–104.
Mitchell, S. N., Smith, K. M., Joseph, M. H., & Gray, J. A. (1993). Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience, 56(4), 989–997.
Montoya, J. G., Kogelnik, A. M., Bhangoo, M., Lunn, M. R., Flamand, L., Merrihew, L. E., et al. (2013). Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. Journal of Medical Virology, 85(12), 2101–2109. doi:10.1002/jmv.23713.
Nakatsuji, Y., Nakano, M., Moriya, M., Kishigami, H., Tatsumi, C., Tada, S., et al. (2006). Beneficial effect of interferon-beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-beta injection. Cytokine, 36(1–2), 69–74. doi:10.1016/j.cyto.2006.10.013.
Nance, D. M., & Sanders, V. M. (2007). Autonomic innervation and regulation of the immune system (1987–2007). Brain, Behavior, and Immunity, 21(6), 736–745. doi:10.1016/j.bbi.2007.03.008.
Neumeister, A., Charney, D. S., Belfer, I., Geraci, M., Holmes, C., Sharabi, Y., et al. (2005). Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenetics and Genomics, 15(3), 143–149.
Niedermaier, O. N., Smith, M. L., Beightol, L. A., Zukowska-Grojec, Z., Goldstein, D. S., & Eckberg, D. L. (1993). Influence of cigarette smoking on human autonomic function. Circulation, 88(2), 562–571.
Niino, M., Kikuchi, S., Miyagishi, R., Fukazawa, T., Yabe, I., & Tashiro, K. (2002). An examination of the association between beta2 adrenergic receptor polymorphisms and multiple sclerosis. Multiple Sclerosis, 8(6), 475–478.
Nowakowska, E., Kus, K., Florek, E., Czubak, A., & Jodynis-Liebert, J. (2006). The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine. Human and Experimental Toxicology, 25(4), 199–209.
Ordia, J. I., Fischer, E., Adamski, E., Chagnon, K. G., & Spatz, E. L. (2002). Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation, 5(1), 16–24. doi:10.1046/j.1525-1403.2002._2004.x.
Osztovits, J., Horvath, T., Littvay, L., Steinbach, R., Jermendy, A., Tarnoki, A., et al. (2011). Effects of genetic vs. environmental factors on cardiovascular autonomic function: A twin study. Diabetic Medicine, 28(10), 1241–1248. doi:10.1111/j.1464-5491.2011.03363.x.
Pagani, M., Lombardi, F., Guzzetti, S., Rimoldi, O., Furlan, R., Pizzinelli, P., et al. (1986). Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circulation Research, 59(2), 178–193.
Pagani, M., Lombardi, F., Guzzetti, S., Sandrone, G., Rimoldi, O., Malfatto, G., et al. (1984). Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects. Journal of Hypertension. Supplement, 2(3), S383–s385.
Pi, F., & Garcia-Sevilla, J. A. (1992). Alpha 2-autoreceptor-mediated modulation of tyrosine hydroxylase activity in noradrenergic regions of the rat brain in vivo. Naunyn-Schmiedeberg’s Archives of Pharmacology, 345(6), 653–660.
Piha, S. J., Ronnemaa, T., & Koskenvuo, M. (1994). Autonomic nervous system function in identical twins discordant for obesity. International Journal of Obesity and Related Metabolic Disorders, 18(8), 547–550.
Pittas, F., Ponsonby, A. L., van der Mei, I. A., Taylor, B. V., Blizzard, L., Groom, P., et al. (2009). Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. Journal of Neurology, 256(4), 577–585. doi:10.1007/s00415-009-0120-2.
Plotsky, P. M. (1987). Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology, 121(3), 924–930. doi:10.1210/endo-121-3-924.
Plotsky, P. M., Cunningham, E. T, Jr, & Widmaier, E. P. (1989). Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrine Reviews, 10(4), 437–458. doi:10.1210/edrv-10-4-437.
Polak, P. E., Kalinin, S., & Feinstein, D. L. (2011). Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain, 134(Pt 3), 665–677. doi:10.1093/brain/awq362.
Popik, P., Kozela, E., & Krawczyk, M. (2003). Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. British Journal of Pharmacology, 139(6), 1196–1202. doi:10.1038/sj.bjp.0705359.
Rajda, C., Bencsik, K., Fuvesi, J., Seres, E., Vecsei, L., & Bergquist, J. (2006). The norepinephrine level is decreased in the lymphocytes of long-term interferon-beta-treated multiple sclerosis patients. Multiple Sclerosis, 12(3), 265–270.
Rajendra Acharya, U., Paul Joseph, K., Kannathal, N., Lim, C. M., & Suri, J. S. (2006). Heart rate variability: A review. Medical and Biological Engineering and Computing, 44(12), 1031–1051. doi:10.1007/s11517-006-0119-0.
Ramesh, S., Wilton, S. B., Holroyd-Leduc, J. M., Turin, T. C., Sola, D. Y., & Ahmed, S. B. (2014). Testosterone is associated with the cardiovascular autonomic response to a stressor in healthy men. Clinical and Experimental Hypertension,. doi:10.3109/10641963.2014.933966.
Rana, B. K., Wessel, J., Mahboubi, V., Rao, F., Haeller, J., Gayen, J. R., et al. (2009). Natural variation within the neuronal nicotinic acetylcholine receptor cluster on human chromosome 15q24: Influence on heritable autonomic traits in twin pairs. Journal of Pharmacology and Experimental Therapeutics, 331(2), 419–428. doi:10.1124/jpet.109.157271.
Rao, F., Wen, G., Gayen, J. R., Das, M., Vaingankar, S. M., Rana, B. K., et al. (2007). Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): Naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation, 115(17), 2271–2281. doi:10.1161/CIRCULATIONAHA.106.628859.
Rao, F., Zhang, K., Zhang, L., Rana, B. K., Wessel, J., Fung, M. M., et al. (2010). Human tyrosine hydroxylase natural allelic variation: Influence on autonomic function and hypertension. Cellular and Molecular Neurobiology, 30(8), 1391–1394. doi:10.1007/s10571-010-9535-7.
Rea, R. F., & Eckberg, D. L. (1987). Carotid baroreceptor-muscle sympathetic relation in humans. American Journal of Physiology, 253(6 Pt 2), R929–R934.
Richard Jennings, J., Allen, B., Gianaros, P. J., Thayer, J. F., & Manuck, S. B. (2015). Focusing neurovisceral integration: Cognition, heart rate variability, and cerebral blood flow. Psychophysiology, 52(2), 214–224. doi:10.1111/psyp.12319.
Riise, T., Nortvedt, M. W., & Ascherio, A. (2003). Smoking is a risk factor for multiple sclerosis. Neurology, 61(8), 1122–1124.
Rink, L., Cakman, I., & Kirchner, H. (1998). Altered cytokine production in the elderly. Mechanisms of Ageing and Development, 102(2–3), 199–209.
Rizzo, M. A., Hadjimichael, O. C., Preiningerova, J., & Vollmer, T. L. (2004). Prevalence and treatment of spasticity reported by multiple sclerosis patients. Multiple Sclerosis, 10(5), 589–595.
Sakuma, T., Morimoto, S., Aota, Y., Takahashi, N., Toyoda, N., Kosaki, A., et al. (2010). Efficacy of clonidine in patients with essential hypertension with neurovascular contact of the rostral ventrolateral medulla. Hypertension Research, 33(6), 633–637. doi:10.1038/hr.2010.41.
Salo, T. M., Viikari, J. S., Antila, K. J., Voipio-Pulkki, L. M., Jalonen, J. O., & Valimaki, I. A. (1996). Antihypertensive treatment and heart rate variability in diabetic patients: Role of cardiac autonomic neuropathy. Journal of the Autonomic Nervous System, 60(1–2), 61–70.
Sanders, V. M., Baker, R. A., Ramer-Quinn, D. S., Kasprowicz, D. J., Fuchs, B. A., & Street, N. E. (1997). Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help. J Immunol, 158(9), 4200–4210.
Sanders, V. M., & Straub, R. H. (2002). Norepinephrine, the beta-adrenergic receptor, and immunity. Brain, Behavior, and Immunity, 16(4), 290–332.
Santulli, G., & Iaccarino, G. (2013). Pinpointing beta adrenergic receptor in ageing pathophysiology: Victim or executioner? vidence from crime scenes. Immunity and Ageing, 10(1), 10. doi:10.1186/1742-4933-10-10.
Sanya, E. O., Tutaj, M., Brown, C. M., Goel, N., Neundorfer, B., & Hilz, M. J. (2005). Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients. Clinical Autonomic Research, 15(3), 213–218. doi:10.1007/s10286-005-0274-7.
Sara, S. J. (2009). The locus coeruleus and noradrenergic modulation of cognition. Nature Reviews Neuroscience, 10(3), 211–223. doi:10.1038/nrn2573.
Sara, S. J., & Bouret, S. (2012). Orienting and reorienting: The locus coeruleus mediates cognition through arousal. Neuron, 76(1), 130–141. doi:10.1016/j.neuron.2012.09.011.
Schrempf, W., & Ziemssen, T. (2007). Glatiramer acetate: Mechanisms of action in multiple sclerosis. Autoimmunity Reviews, 6(7), 469–475. doi:10.1016/j.autrev.2007.02.003.
Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998). Antidepressant-like effects of chronic nicotine on learned helplessness paradigm in rats. Biological Psychiatry, 43(5), 389–391.
Sena, A., Pedrosa, R., & Graca Morais, M. (2003). Therapeutic potential of lovastatin in multiple sclerosis. Journal of Neurology, 250(6), 754–755.
Shearman, E., Rossi, S., Sershen, H., Hashim, A., & Lajtha, A. (2005). Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function. Neurochemical Research, 30(8), 1055–1066. doi:10.1007/s11064-005-7132-9.
Shetty, D. N., & Pathak, S. S. (2002). Correlation between plasma neurotransmitters and memory loss in pregnancy. Journal of Reproductive Medicine, 47(6), 494–496.
Shi, F. D., Piao, W. H., Kuo, Y. P., Campagnolo, D. I., Vollmer, T. L., & Lukas, R. J. (2009). Nicotinic attenuation of central nervous system inflammation and autoimmunity. J Immunol, 182(3), 1730–1739.
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., et al. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry, 54(1), 70–75.
Sicotte, N. L., Giesser, B. S., Tandon, V., Klutch, R., Steiner, B., Drain, A. E., et al. (2007). Testosterone treatment in multiple sclerosis: A pilot study. Archives of Neurology, 64(5), 683–688. doi:10.1001/archneur.64.5.683.
Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., et al. (2002). Treatment of multiple sclerosis with the pregnancy hormone estriol. Annals of Neurology, 52(4), 421–428. doi:10.1002/ana.10301.
Simon, K. C., van der Mei, I. A., Munger, K. L., Ponsonby, A., Dickinson, J., Dwyer, T., et al. (2010). Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology, 74(17), 1365–1371. doi:10.1212/WNL.0b013e3181dad57e.
Sjoberg, N., & Saint, D. A. (2011). A single 4 mg dose of nicotine decreases heart rate variability in healthy nonsmokers: Implications for smoking cessation programs. Nicotine and Tobacco Research, 13(5), 369–372. doi:10.1093/ntr/ntr004.
Song, D. K., Im, Y. B., Jung, J. S., Suh, H. W., Huh, S. O., Song, J. H., et al. (1999). Central injection of nicotine increases hepatic and splenic interleukin 6 (IL-6) mRNA expression and plasma IL-6 levels in mice: Involvement of the peripheral sympathetic nervous system. The FASEB Journal, 13(10), 1259–1267.
Sorensen, T. L., & Sellebjerg, F. (2001). Distinct chemokine receptor and cytokine expression profile in secondary progressive MS. Neurology, 57(8), 1371–1376.
Stadelmann, C., Kerschensteiner, M., Misgeld, T., Bruck, W., Hohlfeld, R., & Lassmann, H. (2002). BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells? Brain, 125(Pt 1), 75–85.
Stein, P. K., Rottman, J. N., & Kleiger, R. E. (1996). Effect of 21 mg transdermal nicotine patches and smoking cessation on heart rate variability. American Journal of Cardiology, 77(9), 701–705.
Sternberg, Z. (2012). Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy. Current Pharmaceutical Design, 18(12), 1635–1644.
Sternberg, Z. (2015). Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies. Autoimmunity Reviews,. doi:10.1016/j.autrev.2015.04.012.
Sternberg, Z., Grewal, P., Cen, S., Debarge-Igoe, F., Yu, J., & Arata, M. (2013a). Blood pressure normalization post-jugular venous balloon angioplasty. Phlebology,. doi:10.1177/0268355513512824.
Sternberg, Z., Leung, C., Sternberg, D., Li, F., Karmon, Y., Chadha, K., et al. (2013b). The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients. CNS and Neurological Disorders: Drug Targets, 12(1), 104–111.
Sternberg, Z., Leung, C., Sternberg, D., Yu, J., & Hojnacki, D. (2014). Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis. Cardiovascular Therapeutics, 32(2), 33–39. doi:10.1111/1755-5922.12049.
Sturm, D., Gurevitz, S. L., & Turner, A. (2014). Multiple sclerosis: A review of the disease and treatment options. The Consultant Pharmacist®, 29(7), 469–479. doi:10.4140/TCP.n.2014.469.
Takahashi, K., Kayama, Y., Lin, J. S., & Sakai, K. (2010). Locus coeruleus neuronal activity during the sleep-waking cycle in mice. Neuroscience, 169(3), 1115–1126. doi:10.1016/j.neuroscience.2010.06.009.
Taylor, J. A., Myers, C. W., Halliwill, J. R., Seidel, H., & Eckberg, D. L. (2001). Sympathetic restraint of respiratory sinus arrhythmia: Implications for vagal-cardiac tone assessment in humans. American Journal of Physiology Heart and Circulatory Physiology, 280(6), H2804–H2814.
Thayer, J. F., Hansen, A. L., Saus-Rose, E., & Johnsen, B. H. (2009). Heart rate variability, prefrontal neural function, and cognitive performance: The neurovisceral integration perspective on self-regulation, adaptation, and health. Annals of Behavioral Medicine, 37(2), 141–153. doi:10.1007/s12160-009-9101-z.
Thayer, J. F., & Lane, R. D. (2000). A model of neurovisceral integration in emotion regulation and dysregulation. Journal of Affective Disorders, 61(3), 201–216.
Thayer, J. F., & Lane, R. D. (2007). The role of vagal function in the risk for cardiovascular disease and mortality. Biological Psychology, 74(2), 224–242. doi:10.1016/j.biopsycho.2005.11.013.
Thorley-Lawson, D. A. (2001). Epstein–Barr virus: Exploiting the immune system. Nature Reviews Immunology, 1(1), 75–82. doi:10.1038/35095584.
Tizabi, Y., Rezvani, A. H., Russell, L. T., Tyler, K. Y., & Overstreet, D. H. (2000). Depressive characteristics of FSL rats: Involvement of central nicotinic receptors. Pharmacology, Biochemistry and Behavior, 66(1), 73–77.
Tomassini, V., Onesti, E., Mainero, C., Giugni, E., Paolillo, A., Salvetti, M., et al. (2005). Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. Journal of Neurology, Neurosurgery and Psychiatry, 76(2), 272–275. doi:10.1136/jnnp.2003.033324.
Torre, D. L., & Falorni, A. (2007). Pharmacological causes of hyperprolactinemia. Therapeutics and Clinical Risk Management, 3(5), 929–951.
Vollmer, T., Key, L., Durkalski, V., Tyor, W., Corboy, J., Markovic-Plese, S., et al. (2004). Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet, 363(9421), 1607–1608. doi:10.1016/S0140-6736(04)16205-3.
Vongpatanasin, W., Tuncel, M., Mansour, Y., Arbique, D., & Victor, R. G. (2001). Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation, 103(24), 2903–2908.
Vukusic, S., Ionescu, I., El-Etr, M., Schumacher, M., Baulieu, E. E., Cornu, C., et al. (2009). The prevention of post-partum relapses with progestin and estradiol in multiple sclerosis (POPART’MUS) trial: Rationale, objectives and state of advancement. Journal of the Neurological Sciences, 286(1–2), 114–118. doi:10.1016/j.jns.2009.08.056.
Wallin, B. G., Esler, M., Dorward, P., Eisenhofer, G., Ferrier, C., Westerman, R., et al. (1992). Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. Journal of Physiology, 453, 45–58.
Wang, H., & Sun, X. (2005). Desensitized nicotinic receptors in brain. Brain Research. Brain Research Reviews, 48(3), 420–437. doi:10.1016/j.brainresrev.2004.09.003.
Wingerchuk, D. M. (2012). Smoking: Effects on multiple sclerosis susceptibility and disease progression. Therapeutic Advances in Neurological Disorders, 5(1), 13–22. doi:10.1177/1756285611425694.
Wong, D. F., Kuwabara, H., Kim, J., Brasic, J. R., Chamroonrat, W., Gao, Y., et al. (2013). PET imaging of high-affinity alpha4beta2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics. Journal of Nuclear Medicine, 54(8), 1308–1314. doi:10.2967/jnumed.112.108001.
Yang, A. C., Chen, T. J., Tsai, S. J., Hong, C. J., Kuo, C. H., Yang, C. H., et al. (2010). BDNF Val66Met polymorphism alters sympathovagal balance in healthy subjects. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B(5), 1024–1030. doi:10.1002/ajmg.b.31069.
Yang, A. C., Tsai, S. J., Hong, C. J., Wang, C., Chen, T. J., Liou, Y. J., et al. (2011). Clustering heart rate dynamics is associated with beta-adrenergic receptor polymorphisms: Analysis by information-based similarity index. PLoS One, 6(5), e19232. doi:10.1371/journal.pone.0019232.
Yildirir, A., Kabakci, G., Akgul, E., Tokgozoglu, L., & Oto, A. (2002). Effects of menstrual cycle on cardiac autonomic innervation as assessed by heart rate variability. Annals of Noninvasive Electrocardiology, 7(1), 60–63.
Yun, A. J., Bazar, K. A., Lee, P. Y., Gerber, A., & Daniel, S. M. (2005). The smoking gun: Many conditions associated with tobacco exposure may be attributable to paradoxical compensatory autonomic responses to nicotine. Medical Hypotheses, 64(6), 1073–1079. doi:10.1016/j.mehy.2004.11.040.
Zakrzewska-Pniewska, B., Golebiowski, M., Zajda, M., Szeszkowski, W., Podlecka-Pietowska, A., & Nojszewska, M. (2011). Sex hormone patterns in women with multiple sclerosis as related to disease activity—A pilot study. Neurologia i Neurochirurgia Polska, 45(6), 536–542.
Zamvil, S. S., & Steinman, L. (2002). Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS. Neurology, 59(7), 970–971.
Zarrindast, M. R., Haidari, H., Jafari, M. R., & Djahanguiri, B. (2004). Influence of beta-adrenoceptor agonists and antagonists on baclofen-induced memory impairment in mice. Behavioural Pharmacology, 15(4), 293–297.
Zhang, Q., Lu, X. N., & Sun, N. L. (2007). Effects of Verapamil and Metoprolol on heart rate variability in patients with coronary heart disease. Beijing Da Xue Xue Bao, 39(6), 610–613.
Zoukos, Y., Thomaides, T. N., Kidd, D., Cuzner, M. L., & Thompson, A. (2003). Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: A longitudinal six month study. Journal of Neurology, Neurosurgery and Psychiatry, 74(2), 197–202.
Acknowledgments
The author thanks Prof. Bernhard Schaller for the intellectual input.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None declared
Rights and permissions
About this article
Cite this article
Sternberg, Z. Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis. Neuromol Med 18, 16–36 (2016). https://doi.org/10.1007/s12017-015-8375-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-015-8375-5